Related Experiment Video
Updated: Jun 29, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain
I Suárez-García1, A Rodríguez-Blanco, J L Vidal-Pérez
1Department of Internal Medicine, Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain. inessuarez@hotmail.com
Summary
Multidrug-resistant tuberculosis (MDR-TB) risk factors include prior tuberculosis treatment and age (45-64 years). Notably, a lack of alcohol abuse history was also associated with MDR-TB in this specialized unit study.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge.
- Identifying specific risk factors is crucial for effective prevention and treatment strategies.
- Previous tuberculosis treatment and patient demographics are potential determinants of drug resistance.
Purpose of the Study:
- To investigate and describe the key risk factors associated with multidrug-resistant tuberculosis (MDR-TB).
- To analyze patient data from a specialized tuberculosis unit to identify predictors of MDR-TB.
- To inform public health interventions by understanding the epidemiology of MDR-TB.
Main Methods:
- Retrospective cohort study design.
- Analysis of medical records from a specialized tuberculosis unit in Madrid, Spain (1997-2006).
- Inclusion criteria: positive M. tuberculosis culture and available drug-susceptibility tests; assessed variables included demographics, lifestyle, medical history, and prior TB treatment.
Main Results:
- Thirty cases of MDR-TB and 666 cases of non-MDR-TB were identified.
- Multivariate analysis revealed significant associations between MDR-TB and previous tuberculosis treatment (OR: 3.44), age group 45-64 years (OR: 3.24), and absence of alcohol abuse (OR: 0.12).
- Patients with prior TB treatment, aged 45-64, or without a history of alcohol abuse showed increased likelihood of MDR-TB.
Conclusions:
- Previous tuberculosis treatment and being in the 45-64 age group are significant risk factors for developing MDR-TB.
- The association of MDR-TB with a lack of alcohol abuse history warrants further investigation.
- Findings highlight the importance of considering treatment history and age in MDR-TB risk assessment.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...